NDATOPICALOINTMENT
Approved
Sep 1991
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
6
Data completeness
3/8 — Basic
DERMATOP (prednicarbate) by Bausch + Lomb. Approved for psoriasis. First approved in 1991.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DERMATOP (prednicarbate) is a topical corticosteroid ointment approved in 1991 for treating psoriasis. It works through anti-inflammatory and immunosuppressive mechanisms characteristic of mid-potency corticosteroids. The product is administered directly to affected skin areas.
LOE Approaching
Product is in late-stage lifecycle with minimal linked job openings, suggesting a consolidating team focused on maintenance rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications (1)
Clinical Trials (6)
Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract
Started Nov 2023
90 enrolled
Allergic RhinitisAllergic AsthmaAllergic Rhinoconjunctivitis+1 more
Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis
Started Jun 2019
125 enrolled
Tinea
Dermatopharmacokinetic Trial of LEO 90100 Foam
Started Mar 2018
58 enrolled
Healthy
Dermatopharmacokinetic Trial of LEO 80185 Gel
Started Nov 2015
32 enrolled
Psoriasis Vulgaris
Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis
Started Aug 2009
260 enrolled
Onychomycosis
Worked on DERMATOP at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.